New: Connect your wearable. Get a peptide protocol tuned to your data.

StacksJuly 20266 min read

GLOW Blend: What GHK-Cu Adds to the Wolverine Stack

GLOW takes the Wolverine Stack's BPC-157 and TB-500 and adds a third peptide studied for a different job entirely: collagen and gene-expression research.

GLOW is the Wolverine Stack — BPC-157 and TB-500 — plus GHK-Cu, a copper-binding tripeptide, co-lyophilized into a single vial. Where Wolverine's two peptides both center on tissue-repair signaling, GHK-Cu's studied mechanism is different: gene expression and collagen remodeling.

The Third Peptide: GHK-Cu

GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper) was first isolated from human plasma in 1973. A 1988 study established that at very low, nontoxic concentrations, it stimulates both synthesis and breakdown of collagen and glycosaminoglycans in fibroblast cultures — the foundational finding behind most of the skin- and tissue-remodeling research that followed.

What the Literature Shows

A 2018 review by Pickart and Margolina in the International Journal of Molecular Sciences surveys the gene-expression data: GHK-Cu applied to skin over 12 weeks improved collagen production in a majority of subjects tested, outperforming both a vitamin C cream and a retinoic acid comparator in the same study, and increased expression of matrix metalloproteinase genes involved in tissue remodeling.

Why Add It to Wolverine

BPC-157 and TB-500 are studied for tissue survival, fibroblast activity, and cell migration at an injury site — the mechanics of repair. GHK-Cu's literature sits one layer up: the quality and composition of the collagen matrix being rebuilt, plus broader gene-expression effects that extend into skin and follicular research. Combining the three is a bet that repair signaling and matrix-remodeling signaling are complementary layers, not that either compound changes how the other works.

What's not established: as with Wolverine, no study tests the three-peptide combination directly. Each compound's evidence comes from studies where it was administered alone or, for GHK-Cu, most often applied topically rather than injected alongside BPC-157/TB-500.

For the BPC-157 and TB-500 mechanisms this blend builds on, see the Wolverine Stack research guide.

Sourcing GLOW

View the GLOW Stack product page

Frequently Asked Questions

Is GLOW just Wolverine with an extra ingredient, or a different formulation?

It's the same BPC-157/TB-500 pairing found in Wolverine, with GHK-Cu added in the same vial — not a reformulation of the first two. Vendors typically keep the BPC-157/TB-500 ratio consistent with their standalone Wolverine product and add GHK-Cu on top.

References

1. Maquart FX, Pickart L, Laurent M, et al. "Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+." FEBS Lett, 1988. PubMed

2. Pickart L, Margolina A. "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." Int J Mol Sci, 2018. PubMed

This article contains affiliate links. Aura Protocols may earn a commission if you purchase through these links at no additional cost to you. All compounds are for research use only.